These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1828046)

  • 21. [Surgical stomatological interventions of patients on anticoagulant therapy (with description of two patients)].
    Ugrinov R
    Stomatologiia (Sofiia); 1989; 71(1):64-8. PubMed ID: 2535295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The international normalization ratio in the monitoring of oral anticoagulant therapy].
    Sansores-García L; Majluf-Cruz AS; Vargas-Vorácková F; Labardini-Méndez J
    Rev Invest Clin; 1993; 45(5):463-7. PubMed ID: 8134728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overuse of prothrombin and partial thromboplastin coagulation tests in medical inpatients.
    Pilsczek FH; Rifkin WD; Walerstein S
    Heart Lung; 2005; 34(6):402-5. PubMed ID: 16324959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. International Committee for Standardization in Haematology, International Committee on Thrombosis and Haemostasis: ICSH/ICTH recommendations for reporting prothrombin time in oral anticoagulant control.
    Thromb Haemost; 1985 Feb; 53(1):155-6. PubMed ID: 3992515
    [No Abstract]   [Full Text] [Related]  

  • 25. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Recommendations of the Hemostasis and Thrombosis Study Group. For better surveillance of anticoagulant therapy by anti-vitamin K agents].
    Nouv Rev Fr Hematol (1978); 1986; 28(5):331-2. PubMed ID: 3808944
    [No Abstract]   [Full Text] [Related]  

  • 28. [Control of oral anticoagulant therapy using the Hepato-Quick-test].
    Heene DL
    Med Welt; 1974 Sep; 25(39):1529-31. PubMed ID: 4214975
    [No Abstract]   [Full Text] [Related]  

  • 29. Falsely elevated INRs in warfarin-treated patients with the lupus anticoagulant.
    Sanfelippo MJ; Sennet J; McMahon EJ
    WMJ; 2000 Jun; 99(3):62-4, 43. PubMed ID: 10927985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of recurrence of thromboembolic disease: maintenance of anticoagulant therapy].
    Enrico JF
    Ther Umsch; 1989 Oct; 46(10):732-8. PubMed ID: 2814910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [PT (INR) in extractive dental surgery in patients treated with oral anticoagulants].
    Caldarola F; Tealdi R; Molinatti M
    Minerva Stomatol; 1994 Apr; 43(4):167-9. PubMed ID: 8065287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral surgery procedures in patients on anticoagulants. Preliminary report.
    Cieślik-Bielewska A; Pelc R; Cieślik T
    Kardiol Pol; 2005 Aug; 63(2):137-40; discussion 141. PubMed ID: 16136412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Standardized prothrombin time test for control of anticoagulant therapy].
    Nilsson IM
    Lakartidningen; 1971 Jun; 68(30):3373-4. PubMed ID: 4106374
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new plastic collection tube made of polyethylene terephtalate is suitable for monitoring traditional anticoagulant therapy (oral anticoagulant, unfractionated heparin, and low molecular weight heparin).
    Toulon P; Ajzenberg N; Smahi M; Guillin MC
    Thromb Res; 2007; 119(2):135-43. PubMed ID: 16426667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinical study monitoring low-intensity anticoagulant therapy with a standard-sensitivity thromboplastin.
    Brophy MT; Fiore LD; Lau J; Headley E; Allen M; Deykin D
    Arch Pathol Lab Med; 1993 Jun; 117(6):618-21. PubMed ID: 8503734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants.
    Glueck HI; Kant KS; Weiss MA; Pollak VE; Miller MA; Coots M
    Arch Intern Med; 1985 Aug; 145(8):1389-95. PubMed ID: 3927865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recommendation of the Group for Studies on Hemostasis and Thrombosis. Toward better supervision of anticoagulant therapy by anti-vitamin K agents].
    Pathol Biol (Paris); 1986 Nov; 34(9):1035-6. PubMed ID: 3543814
    [No Abstract]   [Full Text] [Related]  

  • 39. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.